What if scientists had developed a universal coronavirus vaccine in the years prior to 2020 so that it was available at the start of the COVID-19 pandemic? A universal coronavirus vaccine targets parts of the virus that are common to either many or all coronaviruses, thereby offering some degree of protection against a range of strains. A new study suggests […]
A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection. They also found a higher proportion of individuals with acute symptoms rebound and test-positivity than previously reported. The study appears Jan. 4, 2024, in the Journal of Medical Virology. Paxlovid treatment […]
Theratechnologies Inc. announced that the FDA has approved the company’s Labelling Prior Approval Supplement to include a 2000-mg intravenous (IV) push loading dose for Trogarzo (ibalizumab-uiyk). IV push is a method by which the undiluted medication is “pushed” by syringe for faster administration into the body’s circulation and is designed to make Trogarzo administration easier and more convenient for people […]
Research from experts at Michigan Medicine is highlighting the potential for additional at-home assistance for partners of those who are treated in the emergency department for a sexually transmitted infection. Expedited partner therapy is one method of reducing STI re-infection. It’s a safe, effective, harm-reduction-focused practice of treating sex partner(s) of patients with STIs without a clinical exam of the partner(s). This […]
The spread of false information and conspiracy theories accelerated during the peak of the COVID-19 pandemic. Inadvertently inaccurate, and some deliberately misleading, ideas were widely shared on social media channels on topics ranging from the origin of the SARS-CoV-2 virus to the safety of vaccines. Researchers at Nanyang Technological University, Singapore, set out to understand why COVID-19 misinformation thrived and […]
HPV, or human papillomavirus, is the most common sexually transmitted infection. It is also the leading cause of cervical cancer. Over 1,400 Canadian women are affected yearly, with almost 400 deaths, according to the Canadian Cancer Society. It is completely preventable with the HPV vaccine, and yet, unfortunately, many people are unvaccinated. University of Waterloo researchers have found a possible solution […]
When PrEP (pre-exposure prophylaxis), a drug that prevents HIV infection, was first approved by the FDA in 2012, it was a medical breakthrough that promised to drastically reduce HIV transmission. Traditionally, PrEP is administered via a pill that needs to be taken at the same time every day. Now, there are even more delivery options. A new UConn study explores […]
A new study published today shows the number of sexual partners we have changes as we age – and there are some surprising results. Researchers from the University of East Anglia (UEA), in collaboration with King’s College London and University College London, surveyed more than 5,000 people aged 18 years and older during the 2022 mpox (previously known as “monkeypox”) […]
EU medicines regulators have approved a vaccine to protect against disease caused by the respiratory syncytial virus (RSV). Abrysvo is the first RSV vaccine indicated for passive immunisation of infants from birth through 6 months of age following administration of the vaccine to the mother during pregnancy. This vaccine is also indicated for active immunisation of adults aged 60 years […]
Gilead Sciences, Inc. announced that the FDA approved a supplemental new drug application (sNDA) for the use of Veklury (remdesivir) with no dose adjustments to treat COVID-19 in people with mild, moderate and severe hepatic impairment. This approval further supports the safety profile of Veklury as the first and only approved antiviral COVID-19 treatment that can be used across all […]
Recent Comments